{"key":"orforglipron","slug":"orforglipron","name":"Orforglipron","other_names":[],"kind":"single","area":{"slug":"metabolic","name":"Metabolic"},"classification":"Oral GLP-1 receptor agonist (not a peptide)","standing":{"id":"phase-3","label":"Phase 3 trials","rank":4},"summary":"A small molecule taken by mouth that activates the GLP-1 receptor. It is not a peptide; it is in the library because it is studied beside the peptide agonists.","cas_number":null,"molecular_formula":null,"molecular_weight":null,"components":[],"has_article":false,"pubmed":{"papers":165,"in_humans":93,"clinical_trials":22},"retired":false,"updated_at":"2026-11-18T00:17:24.691Z","url":"https://pepts.wiki/compounds/orforglipron","article":null,"evidence":{"query":"(\"Orforglipron\"[tiab])","fetched_at":"2026-11-16T23:04:08.365Z","counts":{"rcts":20,"human":93,"total":165,"reviews":83,"clinicalTrials":22},"years":[{"year":2012,"count":1},{"year":2013,"count":0},{"year":2014,"count":0},{"year":2015,"count":0},{"year":2016,"count":0},{"year":2017,"count":0},{"year":2018,"count":0},{"year":2019,"count":0},{"year":2020,"count":0},{"year":2021,"count":0},{"year":2022,"count":0},{"year":2023,"count":14},{"year":2024,"count":17},{"year":2025,"count":33},{"year":2026,"count":108}],"top":[{"doi":"10.1056/NEJMoa2511774","url":"https://pubmed.ncbi.nlm.nih.gov/40960239/","kind":"rct","pmid":"40960239","year":2025,"title":"Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment","venue":"The New England journal of medicine","authors":"Wharton S, Aronne LJ, Stefanski A, et al."},{"doi":"10.1136/bmj-2026-372161","url":"https://pubmed.ncbi.nlm.nih.gov/42419792/","kind":"review","pmid":"42419792","year":2026,"title":"Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis","venue":"BMJ (Clinical research ed.)","authors":"Nong K, Shi Q, Xie X, et al."},{"doi":"10.1056/NEJMoa2505669","url":"https://pubmed.ncbi.nlm.nih.gov/40544435/","kind":"rct","pmid":"40544435","year":2025,"title":"Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes","venue":"The New England journal of medicine","authors":"Rosenstock J, Hsia S, Nevarez Ruiz L, et al."},{"doi":"10.1038/s41366-025-01859-6","url":"https://pubmed.ncbi.nlm.nih.gov/40804463/","kind":"review","pmid":"40804463","year":2025,"title":"Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis","venue":"International journal of obesity (2005)","authors":"Ismaiel A, Scarlata GGM, Boitos I, et al."},{"doi":"10.1056/NEJMoa2302392","url":"https://pubmed.ncbi.nlm.nih.gov/37351564/","kind":"rct","pmid":"37351564","year":2023,"title":"Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity","venue":"The New England journal of medicine","authors":"Wharton S, Blevins T, Connery L, et al."},{"doi":"10.1136/bmj-2024-083039","url":"https://pubmed.ncbi.nlm.nih.gov/40813122/","kind":"review","pmid":"40813122","year":2025,"title":"Medications for adults with type 2 diabetes: a living systematic review and network meta-analysis","venue":"BMJ (Clinical research ed.)","authors":"Nong K, Jeppesen BT, Shi Q, et al."},{"doi":"10.1111/dom.15184","url":"https://pubmed.ncbi.nlm.nih.gov/37344954/","kind":"rct","pmid":"37344954","year":2023,"title":"Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants","venue":"Diabetes, obesity & metabolism","authors":"Pratt E, Ma X, Liu R, et al."},{"doi":"10.1126/scitranslmed.adp5765","url":"https://pubmed.ncbi.nlm.nih.gov/39693407/","kind":"study","pmid":"39693407","year":2024,"title":"The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron","venue":"Science translational medicine","authors":"Sloop KW, Cox AL, Wainscott DB, et al."},{"doi":"10.1093/ajhp/zxag144","url":"https://pubmed.ncbi.nlm.nih.gov/42138709/","kind":"study","pmid":"42138709","year":2026,"title":"Orforglipron Calcium","venue":"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","authors":""}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}